Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2012 (2012), Article ID 210529, 7 pages
http://dx.doi.org/10.1155/2012/210529
Clinical Study

A Risk Prediction Index for Amiodarone-Induced Thyrotoxicosis in Adults with Congenital Heart Disease

1Department of Internal Medicine, Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA
2Department of Emergency Medicine, Mayo Clinic, Rochester, MN 55905, USA
3Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
4Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic, Rochester, MN 55905, USA

Received 29 September 2011; Revised 17 November 2011; Accepted 18 November 2011

Academic Editor: Fausto Bogazzi

Copyright © 2012 Marius N. Stan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Marelli, A. S. Mackie, R. Ionescu-Ittu, E. Rahme, and L. Pilote, “Congenital heart disease in the general population: changing prevalence and age distribution,” Circulation, vol. 115, no. 2, pp. 163–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. A. Warnes, R. Liberthson, G. K. Danielson et al., “Task force 1: the changing profile of congenital heart disease in adult life,” Journal of the American College of Cardiology, vol. 37, no. 5, pp. 1170–1175, 2001. View at Google Scholar · View at Scopus
  3. J. Bouchardy, J. Therrien, L. Pilote et al., “Atrial arrhythmias in adults with congenital heart disease,” Circulation, vol. 120, no. 17, pp. 1679–1686, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Warnes, R. G. Williams, T. M. Bashore et al., “ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease),” Circulation, vol. 118, no. 23, pp. e714–e833, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Zimetbaum, “Amiodarone for atrial fibrillation,” The New England Journal of Medicine, vol. 356, no. 9, pp. 935–941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Conen, L. Melly, C. Kaufmann et al., “Amiodarone-induced thyrotoxicosis. Clinical course and predictors of outcome,” Journal of the American College of Cardiology, vol. 49, no. 24, pp. 2350–2355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. G. Shewan and A. J. S. Coats, “Ethics in the authorship and publishing of scientific articles,” International Journal of Cardiology, vol. 144, no. 1, pp. 1–2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Bogazzi, L. Bartalena, and E. Martino, “Approach to the patient with amiodarone-induced thyrotoxicosis,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2529–2535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. A. Eskes and W. M. Wiersinga, “Amiodarone and thyroid,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 23, no. 6, pp. 735–751, 2009. View at Publisher · View at Google Scholar
  10. F. Bogazzi, L. Bartalena, E. Dell'Unto et al., “Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy,” Clinical Endocrinology, vol. 67, no. 4, pp. 533–537, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Thorne, I. Barnes, P. Cullinan, and J. Somerville, “Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease,” Circulation, vol. 100, no. 2, pp. 149–154, 1999. View at Google Scholar · View at Scopus
  12. T. Gaber, T. Häupl, G. Sandig et al., “Adaptation of human CD4+ T cells to pathophysiological hypoxia: a transcriptome analysis,” Journal of Rheumatology, vol. 36, no. 12, pp. 2655–2669, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Martino, M. Safran, F. Aghini-Lombardi et al., “Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy,” Annals of Internal Medicine, vol. 101, no. 1, pp. 28–34, 1984. View at Google Scholar · View at Scopus
  14. S. G. Albert, L. E. Alves, and E. P. Rose, “Thyroid dysfunction during chronic amiodarone therapy,” Journal of the American College of Cardiology, vol. 9, no. 1, pp. 175–183, 1987. View at Google Scholar · View at Scopus
  15. K. J. Harjai and A. A. Licata, “Amiodarone induced hyperthyroidism: a case series and brief review of literature,” Pacing and Clinical Electrophysiology, vol. 19, no. 11, part 1, pp. 1548–1554, 1996. View at Google Scholar · View at Scopus
  16. E. Martino, F. Aghini-Lombardi, S. Mariotti, L. Bartalena, L. Braverman, and A. Pinchera, “Amiodarone: a common source of iodine-induced thyrotoxicosis,” Hormone Research, vol. 26, no. 1–4, pp. 158–171, 1987. View at Google Scholar
  17. M. D. Brennan, D. Z. Erickson, J. A. Carney, and R. S. Bahn, “Nongoitrous (type I) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo,” Thyroid, vol. 5, no. 3, pp. 177–183, 1995. View at Google Scholar · View at Scopus
  18. L. Chiovato, E. Martino, M. Tonacchera et al., “Studies on the in vitro cytotoxic effect of amiodarone,” Endocrinology, vol. 134, no. 5, pp. 2277–2282, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Laupacis, N. Sekar, and I. G. Stiell, “Clinical prediction rules: a review and suggested modifications of methodological standards,” Journal of the American Medical Association, vol. 277, no. 6, pp. 488–494, 1997. View at Google Scholar · View at Scopus
  20. D. Garcia and A. Cheng-Lai, “Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation,” Cardiology in Review, vol. 17, no. 5, pp. 230–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Koyak, J. R. De Groot, and B. J. M. Mulder, “Interventional and surgical treatment of cardiac arrhythmias in adults with congenital heart disease,” Expert Review of Cardiovascular Therapy, vol. 8, no. 12, pp. 1753–1766, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. I. G. Stiell and G. A. Wells, “Methodologic standards for the development of clinical decision rules in emergency medicine,” Annals of Emergency Medicine, vol. 33, no. 4, pp. 437–447, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. E. W. Steyerberg, Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating, Springer, New York, NY, USA, 2009.
  24. K. L. Caldwell, G. A. Miller, R. Y. Wang, R. B. Jain, and R. L. Jones, “Iodine status of the U.S. population, National Health and Nutrition Examination Survey 2003-2004,” Thyroid, vol. 18, no. 11, pp. 1207–1214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. T. G. McGinn, G. H. Guyatt, P. C. Wyer, C. D. Naylor, I. G. Stiell, and W. S. Richardson, “Users' guides to the medical literature XXII: how to use articles about clinical decision rules,” Journal of the American Medical Association, vol. 284, no. 1, pp. 79–84, 2000. View at Google Scholar